|
|
Article: Lupin Pharmaceuticals Inc.(RX/GENERIC DRUGS--Profiles)(Company overview)
- Article from:
- Chain Drug Review
- Article date:
- September 28, 2009
CopyrightCOPYRIGHT 2009 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BALTIMORE -- Lupin Pharmaceuticals Inc. (LPI) is the wholly owned United States subsidiary of Lupin Ltd., one of the five largest pharmaceutical companies in India.
Executives say Lupin is dedicated to delivering high-quality generic and branded medications that are trusted by health care professionals and patients around the world.
Since the launch of its generics division four year ago, LPI has quickly grown into a company with more than $250 million in annual sales.
That growth, the company notes, has helped it become one of the domestic pharmaceutical industry's fastest-growing companies.
Last year LPI was rated as the third ...